2,117
Total Claims
$386K
Drug Cost
224
Beneficiaries
$1,725
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
+22%
Cost per patient vs peers
$1,725 vs $1,411 avg
+71%
Brand preference vs peers
18.2% vs 10.6% avg
Brand vs Generic
82% generic
Brand: 378 claims · $343K
Generic: 1,697 claims · $42K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 30 | $57K |
| Dapagliflozin Propanediol | 25 | $42K |
| Semaglutide | 22 | $40K |
| Insulin Aspart | 17 | $29K |
| Sitagliptin Phosphate | 18 | $27K |
| Insulin Detemir | 13 | $12K |
| Insulin Glargine,hum.Rec.Anlog | 13 | $11K |
| Insulin Lispro Protamin/Lispro | 12 | $6,726 |
| Atorvastatin Calcium | 173 | $4,499 |
| Gabapentin | 59 | $2,918 |
| Metformin Hcl | 95 | $1,738 |
| Albuterol Sulfate | 53 | $1,674 |
| Losartan Potassium | 60 | $1,599 |
| Levetiracetam | 13 | $1,531 |
| Levothyroxine Sodium | 54 | $1,213 |
Prescribing Profile
Patient Profile
64
Avg Age
52%
Female
1.36
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About